Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
6,27 USD | -3,09% |
|
-0,48% | -43,05% |
12/06 | Transcript : Relay Therapeutics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 08:40 AM | |
06/06 | Transcript : Relay Therapeutics, Inc. - Special Call |
Attività
Numero di dipendenti: 309
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Dynamo Platform
100,0
%
| 1 | 100,0 % | 26 | 100,0 % | +1.749,82% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 | 100,0 % | 26 | 100,0 % | +1.749,82% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Sanjiv Patel
CEO | Chief Executive Officer | 50 | 01/03/17 |
Mark Murcko
FOU | Founder | 64 | 04/05/15 |
Alexis Borisy
FOU | Founder | 52 | 04/05/15 |
Thomas Catinazzo
DFI | Director of Finance/CFO | 47 | 01/04/18 |
Imogen Pryce
COO | Chief Operating Officer | - | 01/02/20 |
Ben Wolf
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/19 |
Donald Bergstrom
CTO | Chief Tech/Sci/R&D Officer | 52 | 01/04/18 |
Jeanne Gray
HRO | Human Resources Officer | - | - |
Patrick Riley
PRN | Corporate Officer/Principal | - | 10/05/21 |
Brian Adams
LAW | General Counsel | 50 | 01/03/18 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Douglas Ingram
BRD | Director/Board Member | 61 | 01/06/19 |
Linda Hill
BRD | Director/Board Member | 67 | 09/10/18 |
Jami Rubin
BRD | Director/Board Member | 60 | 01/10/19 |
Alexis Borisy
FOU | Founder | 52 | 04/05/15 |
Laura Shawver
BRD | Director/Board Member | 66 | 01/03/17 |
Mark Murcko
FOU | Founder | 64 | 04/05/15 |
Sanjiv Patel
CEO | Chief Executive Officer | 50 | 01/03/17 |
Sekar Kathiresan
BRD | Director/Board Member | 52 | 25/07/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 132 741 677 | 129 603 131 ( 97,64 %) | 0 | 97,64 % |
Coordinate società
![Indirizzo Relay Therapeutics, Inc.(RLAY)](https://cdn.zonebourse.com/static/address/109761182.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-43,05% | 832 Mln | |
+16,59% | 44,44 Mrd | |
+41,02% | 39,84 Mrd | |
-10,62% | 37,68 Mrd | |
+29,92% | 31,46 Mrd | |
-9,23% | 27,02 Mrd | |
+12,34% | 26,29 Mrd | |
+41,53% | 13,8 Mrd | |
+31,49% | 12,46 Mrd | |
-7,40% | 11,26 Mrd |
- Borsa valori
- Azioni
- Azione RLAY
- Società Relay Therapeutics, Inc.